1245768

Oksana Hamidi, DO — FEI 3031224816

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)